Background-The decision-making role of exercise echocardiography in the surgical timing for aortic regurgitation remains a matter of debate because of limited data on its link with outcome. The aim of this study was to assess the role of echocardiographic measurements at rest and during exercise as predictors of valve surgery in asymptomatic aortic regurgitation.
A lthough surgery remains a cornerstone of management in symptomatic severe aortic regurgitation (AR), decision making in asymptomatic chronic AR is less straightforward. [1] [2] [3] The current American College of Cardiology/ American Heart Association (ACC/AHA) and European Society of Cardiology (ESC) guidelines designate a class I or class IIa indication for aortic valve surgery in chronic asymptomatic severe AR if cardiac dysfunction, defined as resting left ventricular (LV) ejection fraction (EF) ≤50%, or severe LV dilatation, is present. 4, 5 However, symptoms may be unrecognized, AR severity may be overestimated or underestimated, LV dilatation and decrease in LVEF once present may not always normalize after corrective surgery, and surgical risks continue to decrease. 1 In addition, moderate AR may progress. 6 Therefore, guidelines designate a class I recommendation for serial echocardiographic testing, with echocardiography to be repeated at least yearly in the setting of moderately severe and severe AR.
Clinical Perspective on p 362
Dilemmas in the management of chronic AR carry some similarities to the ones encountered in the management of mitral regurgitation, another volume overload state that can lead to asymptomatic cardiac dysfunction. Therefore, it is not surprising that markers of cardiac dysfunction shown to be associated with poor outcome in mitral regurgitation, such as exercise LV volumes, resting myocardial strain, and resting myocardial strain rate, are also predictors of need for valve surgery in chronic AR. [7] [8] [9] [10] [11] [12] In contrast, it is unknown whether right ventricular (RV) dysfunction, which seems to be relevant to the outcomes in mitral regurgitation, 13 carries any importance in chronic AR. We have recently developed a framework of assessing incremental value of resting and exercise parameters of both LV and RV function as prognostic parameters of surgical intervention in chronic asymptomatic mitral regurgitation. 13 In this article, we apply a similar framework to identify the independent and incremental value of LV and RV function at rest and during exercise in predicting future surgical intervention in patients with asymptomatic AR without the need (ie, without class I or IIa indication) for surgery, but with the need for at least annual echocardiographic follow-up.
Methods

Study Sample
Between January 2006 and January 2012, consecutive asymptomatic patients with moderately severe to severe AR (vena contracta≥0.3 cm and effective regurgitant orifice [ERO] area≥20 mm, 2 regurgitant fraction≥40%, or regurgitant volume≥45mL) 14 were referred for exercise stress echocardiography at the Cleveland Clinic for the assessment of functional impact of AR. Clinical variables were prospectively gathered from the patients and their medical records at the time of the exercise echocardiogram. We selected patients with preserved LV systolic function (LVEF>50%, LV end-diastolic diam-eter≤70 mm, LV end-systolic diameter≤50 mm, and LV end-systolic diameter/body surface area≤25 mm/m 2 ). Based on an assumed rate of aortic valve surgery of ≈30% during a follow-up period, we anticipated 160 patients would be needed to develop a stable statistical model with 5 predictor variables. 15 The protocol was approved by the Cleveland Clinic Institutional Review Board.
Echocardiographic Assessment at Rest and After Exercise
Transthoracic echocardiography was performed by experienced sonographers before and after symptom-limited exercise using a commercially available ultrasound machine (Vivid 7 or Vivid 9, GE Vingmed, Horten, Norway, Sonos 5500 or iE33, Philips, Andover, MA). All patients underwent symptom-limited exercise treadmill testing using standard treadmill protocols with 12-lead ECG monitoring. At a usual interval of 1 to 2 minutes after exercise (ie, after acquisition of the wall motion study postexercise, sometimes with an additional delay to allow for acquisition of tricuspid regurgitation velocity), 2-dimensional (2D) and Doppler echocardiographic imaging data were obtained again. 16 The duration of the exercise was measured, and the maximal exercise tolerance was expressed as estimated metabolic equivalents (METs). Predicted exercise capacity was calculated in accordance with described nomograms (predicted 10 17 and percentage predicted METs (%PMETs) were described as the difference between actual and predicted METs divided by predicted METs. The regurgitant volume of the AR was calculated as the difference between aortic and pulmonic ejection volume, whereas the regurgitant fraction was calculated as the regurgitant volume divided by the total stoke volume. The ERO area was calculated as the regurgitant volume divided by the time-velocity integral of the AR flow. Based on these calculations, severe AR was defined as an ERO area≥30 mm 2 or regurgitant volume≥60 mL/beat. 14 For the validation of regurgitant volume, LV end-diastolic volume (LVEDV), and end-systolic volume (LVESV), we used data from 25 patients from our initial series of 295 patients who also had a cardiac magnetic resonance (CMR) study performed to assess AR severity. The details of these measurements have already been described. 18, 19 In brief, velocity-encoded MR imaging was performed. The integral of flow rate was calculated for backward flow during diastole (regurgitant volume) with commercially available software (Philips Extended MR Workspace, Philips Medical Systems). The CMR measurements were performed independently and without the knowledge of echocardiographic findings.
LV Function
End-diastolic and end-systolic LV dimensions were measured from the M-mode echocardiogram. LVEDV, LVESV, and LA volumes were calculated by the Simpson method using 2D and indexed to body surface area. The transmitral early diastolic velocity (E) and peak atrial filling velocity (A) were acquired in the apical 4-chamber view. The systolic (s′), early diastolic (e′), and late diastolic (a′) mitral annular tissue velocities were also measured in the apical 4-chamber view with the sample volume positioned at both the septal and lateral mitral annulus; we used the average values of these 2 positions. LV peak longitudinal strain measurements were obtained from gray-scale images recorded in the apical 4-chamber, 2-chamber, and long-axis views. LV strain was analyzed offline using velocity vector imaging (Syngo VVI, Siemens Medical Solutions, Mountain View, CA). 13 After manual definition of the LV endocardial border, the endocardium was automatically tracked throughout the cardiac cycle. Global LV strain was obtained by averaging all segmental strain values from the apical 4-chamber, 2-chamber, and long-axis views. After peak exercise, LVEDV, LVESV, LVEF, transmitral flow velocities, and mitral annular tissue velocities were re-evaluated.
Right Ventricular Function
Standard echocardiographic measurements of the RV were made in accordance with current guidelines. 20 RV fractional area change (RVFAC) was defined using the formula (end-diastolic area−end-systolic area)/end-diastolic area×100). Tricuspid annular plane systolic excursion (TAPSE) was measured as the distance of systolic movement of the junction between the tricuspid valve and the RV free wall using 2-dimensional images. 21 Systolic pulmonary artery pressure (SPAP) was estimated from the maximal continuous-wave Doppler velocity of the TR jet using systolic transtricuspid pressure gradient calculated by the modified Bernoulli equation and the addition of estimated right atrial pressure as previously described. 22 RV strain was measured offline (Syngo VVI). 13 The endocardial border of the RV was traced from an apical 4-chamber view, and segmental strain curves were generated automatically. Peak strain for the 3 RV free wall segments was averaged to produce global RV longitudinal strain ( Figure 1 ). All measurements were made offline by an investigator blinded to all clinical and demographic information. After peak exercise, SPAP and TAPSE were re-evaluated. All measurements were performed and averaged during 3 cardiac cycles.
Clinical Outcomes
Patients were followed in accordance with current guidelines (clinical follow-up visits every 6 to 12 months and echocardiography annually), 4 with the end points of aortic valve surgery or death of any cause. The decision to eventually refer the subject for valve surgery was made by the patient's physician based on development of symptoms, LV dilatation, LV dysfunction, or results of exercise study during follow-up. LV strain and quantitative RV function data were not a part of the exercise study report, and the clinical management was independent of these measurements.
Statistical Analysis
We used SPSS 20.0 software (SPSS Inc, Chicago, IL) unless otherwise noted. Data are presented as mean±SD if the Kolmogorov-Smirnov test showed a normal distribution. Otherwise, the median and interquartile ranges were used. To assess prognostic value of echocardiographic variables tested, we used a similar statistical approach as in our previous article. 13 Median values of resting global LV strain, exercise LVEDV, resting RV strain, and exercise TAPSE were used to divide patients into 2 equal groups for Kaplan-Meier analysis, with survival compared using a 2-sided log-rank test. The association of echocardiographic parameters with outcome was identified by Cox proportional-hazards models in univariable and multivariable analyses. Variables with a univariable value of P<0.10 after adjustment for age and sex were incorporated into the multivariable models that also included terms for interactions between echocardiographic variables. To avoid collinearity in situations where >1 variable measured the same physiological parameter (eg, RVFAC and RV strain as markers of resting RV function), separate models were created for each categorical variable (resting LV function, exercise LV function, resting RV function, and exercise RV function). A hazard ratio with a 95% confidence interval (CI) was calculated for each variable. The assumption of proportional hazards was assessed by plotting the scaled Schoenfeld residuals for each independent variable against time; these correlations were found to be nonsignificant. Sequential Cox models were performed to determine the incremental prognostic benefit of echocardiographic parameters over clinical data, with incremental prognostic value being defined by a significant increase in global χ 2 . To evaluate the predictive ability of our final model, we used Harrell C concordance statistic calculated by STATA 13.0 software (StataCorp, College Station, TX).
To assess the overall differences on LV volumes, EF, and exercise capacity between groups without versus with an event, we applied a Linear Mixed Effects model with unstructured covariance for random effects. 23 We tested the effects of groups as a factor, time after initial echocardiographic assessment as a covariate, as well as time×group interactions. Interobserver and intraobserver variability was examined for regurgitant volume, resting LV strain, resting RV strain, exercise LVEDV, and exercise TAPSE. Measurements were performed in a group of 15 randomly selected subjects by 1 observer and then repeated on 2 separate days by 2 observers who were unaware of the measurements of the others and of the study time point. Statistical significance was defined by P<0.05. The above statistics are demographic, clinical, and echocardiographic data in asymptomatic aortic regurgitation (AR). ACE indicates angiotensin-converting enzyme; ARB, angiotensin II receptor blockers; A-wave, transmitral atrial filling wave; a′ velocity, late diastolic mitral annular tissue velocity; DT, deceleration time; E/e′, the ratio of transmitral early diastolic wave (E) velocity and early diastolic mitral annular tissue (e′)velocity; EF, ejection fraction; ERO, effective regurgitant orifice; E-wave, transmitral early diastolic wave; FAC, fractional area change; LAVi, left atrial volume index; LV, left ventricular; METS, estimated metabolic equivalents; RV, right ventricular; SPAP, systolic pulmonary artery pressure; s′ velocity, systolic mitral annular tissue velocity; and TAPSE, tricuspid annular plane systolic excursion. 
Results
Study Sample
During the study period, we identified 295 consecutive asymptomatic patients undergoing exercise echocardiography with chronic AR. From this group, we excluded patients with more than mild concomitant valvular disease (n=61), atrial fibrillation or flutter (n=4), stress-induced myocardial ischemia or scar (n=15), severe aortic root disease (aortic diameter≥50 mm; n=5), or moderate AR (n=24). We also excluded 27 patients (15%) where the relevant rest (n=10) and exercise (n=17) echocardiographic parameters could not be measured. A total of 159 patients were included for the final analysis, and there are no missing data in our final study sample. Seventy-nine patients (50%) had severe AR ( Figure 2 ). Male patients constituted 80% of our population (Table 1) . This reflects the disproportionate number of male versus female patients with bicuspid aortic valve pathology (90% of patients with bicuspid aortic valve were male). There was a significant increase in TAPSE during exercise in patients who did not subsequently undergo surgery (P<0.001). On the contrary, there was no significant difference in TAPSE between rest and exercise in patients who subsequently underwent surgery (P=0.59; Figure 3 ).
Event-Free Survival
During a period of 30±21 months (range, 1-83 months), 50 patients (31%) reached the clinical end point of aortic valve repair or replacement, and no patient died during follow-up. The decision for aortic valve surgery was driven by the occurrence of symptoms alone in 22 patients, the development of new resting LV dysfunction or dilation alone in 9 patients, and by both criteria in 19 patients. Figure 4A illustrates the time-to-valve replacement of patients with asymptomatic AR stratified according to median values of LV function. Figure 4B also illustrates the time-to-valve replacement stratified according to median values of RV function. In addition, to eliminate the impact of initial testing on the decision to perform surgery, we reanalyzed the data after excluding 14 patients who had surgery within 3 months of the stress test. Figure 4C and 4D illustrates the time-to-valve replacement of patients with asymptomatic AR stratified according to the same variables.
Predicting Time-to-Valve Surgery
The unadjusted hazard ratios obtained by Cox proportional-hazards regression are shown in Data Supplement I. Hazards ratios of the relevant parameters after adjustment for age and sex are shown in (Tables 3-5 ). In addition, we also reanalyzed the models after excluding 14 patients who had surgery within 3 months of the stress test. ERO area, regurgitant volume, regurgitant fraction, vena contracta, global LV strain, RV end-diastolic area, RV end-systolic area, RV strain, exercise LVEDV, exercise SPAP, and exercise TAPSE were also associated with time-to-valve replacement, independent of age and sex (Table 2 ). In multivariable Cox proportional-hazards models, exercise LVEDV was not independently associated with time-to-valve replacement (HR, 1.31; 95% CI [0.87-1.98]; P=0.19, model 3; Tables 3-5 ). Finally, no interaction term was significant.
The incremental benefit of echocardiographic parameters in the prediction of valve replacement is shown in Figure 5A . Figure 5B) . For our Cox model based on age, sex, EROA, LV strain, exercise LVEDV, RV strain, and exercise TAPSE, the Harrell C concordance statistic was calculated to be 0.817.
Echocardiographic Follow-Up
In our cohort, 115 patients (72%) underwent resting echocardiographic follow-up studies, whereas 46 patients (29%) also underwent exercise echocardiographic follow-up studies. Thirty-two patients (20%) underwent aortic valve replacement in this cohort during follow-up. Changes of LVEDV, LVESV, LVEF, and exercise capacity (METs) during follow-up are shown in Figure 6 . LVEDV, LVESV, LVEF, and METs at baseline (initial exercise echocardiography) were similar in patients with and without subsequent surgery (all P>0.05). However, during follow-up, LVEDV and LVESV showed significant increase (LVEDV, P=0.004; LVESV, P=0.002), with a larger increase in patients who subsequently underwent surgery (P<0.001 for the difference in slopes for both LVEDV and LVESV). Furthermore, there was a decrease of LVEF during follow-up in patients who subsequently underwent surgery (P<0.001 for the difference in slopes). Interestingly, there was no change in exercise capacity during follow-up and no difference between the 2 groups in exercise capacity (all P>0.05).
Observer Variability
Interobserver and intraobserver variabilities are reported in Table 6 . These results were similar to what we have shown in the mitral regurgitant population. 13 In addition, the limits of agreement between 2D and anatomic M-mode of TAPSE were ±2.1 mm, with a strong correlation between the 2 methods at rest (r=0.98; P<0.001) and exercise (r=0.95; P<0.001; overall: r=0.96; P<0.001; Data Supplement II).
Accuracy of Regurgitant and LV Volume Measurements
There were good correlations between echocardiography and CMR values of regurgitant volume (r=0.80; P<0.001), LVEDV (r=0.86; P<0.001), and LVESV (r=0.82; P<0.001), with echocardiography measurements slightly underestimating LV volumes and slightly overestimating regurgitant volume (Data Supplement III).
Discussion
Our study of patients with asymptomatic AR, who were undergoing exercise echocardiography, showed that resting LV dysfunction (global LV strain), resting RV dysfunction (global RV strain), and exercise RV dysfunction (TAPSE) were independent predictors of future aortic valve surgery. Resting and exercise RV assessment provided incremental prognostic value over clinical parameters, resting AR severity, and resting global LV strains. Importantly, patients who eventually underwent surgery had similar initial LV volumes and EF but showed a progression of LV dilatation and dysfunction during follow-up. This progression further implies the presence of subclinical cardiac dysfunction in these patients at an earlier stage of AR.
Rest and Exercise LV Dysfunction as a Predictor of Valve Surgery
The results of this study are consistent with the previous work linking resting global LV strain with outcome in asymptomatic regurgitant lesions. [8] [9] [10] [11] Although global LV strain is correlated to LVEF, it may be more sensitive in detecting subclinical myocardial dysfunction 24 in the presence of a pathological process such as AR, even when EF is normal. Although LVEF and volumes during exercise were associated with outcome in asymptomatic AR, in contrast to a previous report, 12 neither was independently associated with the outcomes in patients without the inclusion of patients who had surgery within 3 months of the stress test (Tables 3-5). A likely reason for this discrepancy is that we excluded patients who underwent surgery within 3 months of stress testing because the presence of worse exercise EF supports recommendation for earlier surgery, and its inclusion as a predictor may lead to circular reasoning. Another possible reason is that recovery of LV function may occur before image acquisition.
Rest and Exercise RV Dysfunction as a Predictor of Valve Surgery
The relevance of RV function on outcome in asymptomatic AR has not been extensively investigated. Recently, there has been increasing recognition of the prognostic information provided by RV function in heart failure and pulmonary hypertension. 25, 26 However, it is difficult to assess RV function with standard echocardiographic measurements, especially during exercise, because of the complex shape of the chamber. 27 In the present study, several parameters of resting RV function (eg, RVFAC and RV strain) showed association with valve surgery. Although we were not able to measure them during exercise, TAPSE, a simpler RV function parameter that is easy to measure during exercise, 13 also showed an independent association with valve surgery. The addition of exercise TAPSE significantly improved the prognostic power of a model containing clinical variables. The results suggest that exercise RV dysfunction may further help decision making in asymptomatic AR.
Pathogenesis of RV Dysfunction
The cause of RV dysfunction with exercise in AR is not well characterized. One explanation is that LV dysfunction leads to increased LV filling pressure, with increased pulmonary venous and arterial pressure during exercise, in turn increasing RV afterload. Indeed, in our population, resting SPAP correlated with resting RV strain (r=0.17; P=0.036), whereas exercise SPAP correlated with exercise TAPSE (r=0.19; P=0.013). In addition, neither rest nor exercise SPAP correlated with resting AR severity. These results suggest that increased RV afterload may not be the sole reason for RV dysfunction. This may be indicative of possible primary myocardial changes (eg, fibrosis) 28 or ventriculo-ventricular interaction as a mechanism for the RV changes. 29
Time Course of Asymptomatic AR
In AR, the long-term increase in load results in progressive LV dilatation and dysfunction. Our echocardiographic follow-up data show that, although both groups had similar baseline values, LV size and function (LVEF) in the surgical group deteriorated while being stable in the nonsurgical group throughout 5 years of follow-up. These data suggest that subclinical cardiac dysfunction brought about by AR may be present in some patients at baseline and may be subsequently manifested by LV dilatation and dysfunction. Interestingly, there was no difference between surgical and nonsurgical groups in exercise capacity. Although this may well be because of the fact that our sample size with repeated exercise testing was small, exercise capacity is influenced by a variety of clinical factors. 30 Because our patients had preserved exercise capacity at baseline and were relatively young, this may have influenced exercise capacity during follow-up.
Limitations
This was a single center study that included a selected population of patients with asymptomatic AR and was not a prospective randomized clinical trial. In addition, the sample size was small with relatively few events, which poses a potential risk of model overfit. The present study should be considered as hypothesis generating, and we think larger multicenter studies are warranted. Despite the exclusion of surgical patients within the first 3 months, we may not have been able to avoid the potential inclusion of patients having a decision to perform surgery based on a baseline exercise study. AR severity was measured based on echocardiographic parameters, and these have inherent measurement variability. We were not able to quantify changes in systolic velocity of the tricuspid annulus and ERO at peak exercise. Velocity vector imaging is vendor-independent strain software that is relatively easy to use but with clinical use that remains unproven. We also acknowledge there may be physiological differences to another type of exercise protocol (eg, supine bicycle). These findings may not be interchangeable with another exercise protocol type.
Conclusions
In asymptomatic AR, resting global LV strain, resting RV strain, and exercise TAPSE were independently associated with the need for earlier aortic valve surgery. Moreover, the patients who subsequently underwent surgery showed a significant progression of LV dilatation and dysfunction in a period between initial exercise echocardiogram and surgery. Assessment of resting and exercise RV function may be a useful adjunct to conventional clinical indices and LV function assessment in timing of surgery in asymptomatic patients with moderately severe or severe AR.
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